Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 4 of 15
(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer
NCT03837821
PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT)
NCT03663218
Randomization of Single vs Multiple Arterial Grafts
NCT03217006
RCT of Mobile Apps & FitBit v. Usual Care
NCT03623464
Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
NCT02998268
Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC
NCT02913196
Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations
NCT02917421
Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC
NCT03042468
A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
NCT04691960
Trial to Compare Radiation Fibrosis With Five Versus Three Fractions
NCT02755896
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation
NCT01810588
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma
NCT01559935
Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study
NCT01054196
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
NCT00859781
Whole-Body Hyperthermia for Mood and Anxiety Disorders
NCT06144294
A Personalized Voice Restoration Device for Patients With Laryngectomy
NCT05479643
Technology dRiven Enhancement to Engage & Connect
NCT06910683
Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures
NCT06579989
Novel Delivery Method of Transgender Voice Modification Training Using a Mobile Application
NCT05815810
Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2
NCT07485712
Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1
NCT05811338
Neuromodulation of Mood Switch Circuitry in Bipolar Disorder
NCT07680153
Biomarker-Guided Antidepressant Selection
NCT07680140
Mobile Cognitive Behavioral Therapy in Early Stroke Recovery
NCT07639606
Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade
NCT07661966
Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC
NCT04298541
Biologic Injection For Adults With Lumbar Disc Herniation
NCT07386548
Implementation of a Clinical Decision Support Tool for Postpartum Depression
NCT06818734
Stent Related Symptoms Defined by Ureteral Stent Symptom Questionnaire in Patients With Image-Informed Ureteral Stent Lengths
NCT07580963
Precision Brain Mapping to Predict and Track Response to Exposure and Response Prevention Therapy in Youth With Obsessive-Compulsive Disorder
NCT07570108
Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain Relief
NCT07501676
Effect of Music on Pain and Anxiety During Nail Biopsies
NCT07518953
Biologic Augmentation of TMJ Arthroscopy Using BMAC
NCT07536399
Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
NCT07090174
Technology-Based Intervention Usability and Pilot Testing
NCT07146581
Local Methotrexate Injections for the Treatment of Nail Psoriasis
NCT06578728
Use of Gocovri to Improve Disability Due to Radiation Encephalopathy
NCT07125222
Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD
NCT06488157
Telehealth Group Counseling and Preventive Care for Women
NCT06404515
Analysis of Biologic Signatures in Crohn's Patients Undergoing Surgery
NCT06146335
Mobile Cognitive Behavioral Therapy for Medical and Graduate Students
NCT05823922
Comparison of Community Reintegration Interventions When Using a Simulated Environment
NCT06646939
Developing and Testing Culturally Based Educational Videos for Puerto Rican and African American Home Hospice Caregivers
NCT06024278
Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination
NCT05820295
Analysis of Impact of KeryFlex on Quality of Life for Retronychia or Lichen Planus Adult Patients
NCT05699499
Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding
NCT05711524
Split Face Study of the Duration of Local Anesthetics
NCT05767749
Diabetes Care for Breast Cancer Patients
NCT05565534
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
NCT04673175
Improving How People Living With Dementia Are Selected for Care Coordination
NCT05651308
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets.Report a data error.